Medipole Hopital Prive
- Address
- lock Available on a paid plan
Medipole Hopital Prive - Multidisciplinary Clinical Research Center
Medipole Hopital Prive is a comprehensive clinical research facility conducting innovative trials across multiple therapeutic areas. The center demonstrates particular expertise in infectious disease management, dermatological conditions, and oncology research, with a focus on evaluating novel treatment approaches and therapeutic alternatives to standard care.
- Infectious disease trials examining catheter-related bloodstream infections and antibiotic therapy optimization for Staphylococcus aureus
- Dermatology research investigating early intervention strategies in plaque psoriasis using advanced biologic therapies
- Gastrointestinal oncology studies exploring microbiome-based interventions combined with immunotherapy for metastatic gastric adenocarcinoma
The center's research portfolio reflects a commitment to advancing precision medicine approaches, including studies on single-dose antibiotic regimens, IL-17 inhibition in chronic inflammatory conditions, and gut microbiome modulation in cancer immunotherapy. By participating in multicenter collaborative trials, Medipole Hopital Prive contributes to developing evidence-based treatment strategies that may improve patient outcomes and reduce treatment burden across diverse patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 5 therapeutic areas and 15 of 49 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 43 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medipole Hopital Prive
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation. | Glaxosmithkline Research & Development Limited | Phase III | Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 49 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ambroxol Hydrochloride | 1 | Unknown | 2023-06-23 | 2023-06-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.